Annual Current Ratio
14.25
-3.02-17.49%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual current ratio is 14.25, with the most recent change of -3.02 (-17.49%) on December 31, 2023.
- During the last 3 years, KROS annual current ratio has fallen by -23.02 (-61.77%).
- KROS annual current ratio is now -61.77% below its all-time high of 37.27, reached on December 31, 2020.
Performance
KROS Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
19.03
-1.34-6.58%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly current ratio is 19.03, with the most recent change of -1.34 (-6.58%) on September 30, 2024.
- Over the past year, KROS quarterly current ratio has increased by +4.78 (+33.54%).
- KROS quarterly current ratio is now -48.94% below its all-time high of 37.27, reached on December 31, 2020.
Performance
KROS Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
KROS Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.5% | +33.5% |
| 3 y3 years | -61.8% | -7.3% |
| 5 y5 years | +539.0% | - |
KROS Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | at low | -23.1% | +33.5% |
| 5 y | 5-year | -61.8% | +616.1% | -48.9% | +856.3% |
| alltime | all time | -61.8% | +616.1% | -48.9% | +856.3% |
Keros Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 19.03(-6.6%) |
| Jun 2024 | - | 20.37(-17.7%) |
| Mar 2024 | - | 24.74(+73.6%) |
| Dec 2023 | 14.25(-17.5%) | 14.25(-21.8%) |
| Sep 2023 | - | 18.23(-12.2%) |
| Jun 2023 | - | 20.77(-11.4%) |
| Mar 2023 | - | 23.43(+35.7%) |
| Dec 2022 | 17.27 | 17.27(-19.0%) |
| Sep 2022 | - | 21.33(+48.2%) |
| Jun 2022 | - | 14.39(-27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 19.85(-6.5%) |
| Dec 2021 | 21.23(-43.0%) | 21.23(+3.5%) |
| Sep 2021 | - | 20.52(-36.0%) |
| Jun 2021 | - | 32.06(+12.1%) |
| Mar 2021 | - | 28.60(-23.3%) |
| Dec 2020 | 37.27(+1772.9%) | 37.27(+86.4%) |
| Sep 2020 | - | 19.99(+11.6%) |
| Jun 2020 | - | 17.91(+170.1%) |
| Mar 2020 | - | 6.63(+233.2%) |
| Dec 2019 | 1.99(-10.8%) | 1.99 |
| Dec 2018 | 2.23 | - |
FAQ
- What is Keros Therapeutics annual current ratio?
- What is the all time high annual current ratio for Keros Therapeutics?
- What is Keros Therapeutics annual current ratio year-on-year change?
- What is Keros Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Keros Therapeutics?
- What is Keros Therapeutics quarterly current ratio year-on-year change?
What is Keros Therapeutics annual current ratio?
The current annual current ratio of KROS is 14.25
What is the all time high annual current ratio for Keros Therapeutics?
Keros Therapeutics all-time high annual current ratio is 37.27
What is Keros Therapeutics annual current ratio year-on-year change?
Over the past year, KROS annual current ratio has changed by -3.02 (-17.49%)
What is Keros Therapeutics quarterly current ratio?
The current quarterly current ratio of KROS is 19.03
What is the all time high quarterly current ratio for Keros Therapeutics?
Keros Therapeutics all-time high quarterly current ratio is 37.27
What is Keros Therapeutics quarterly current ratio year-on-year change?
Over the past year, KROS quarterly current ratio has changed by +4.78 (+33.54%)